If you take a GLP-1 and feel dizzy, have shortness of breath, severe abdominal pain or swelling in your neck, you should get medical care right away
Developed by Eli Lilly, retatrutide simultaneously targets GLP-1, GIP, and glucagon receptors a mechanism that sets it apart from currently approved medicines such as semaglutide and tirzepatide
What you give up: the FDA premarket review for safety, effectiveness, and quality that the brand-name finished product carries
However, as discussed by Thomas and Cherney, SGLT inhibitors not only affect glucose metabolism, but also adiposity, renal function and blood pressure in type 2 diabetes
Persistent hunger throughout the day, no change in food noise or cravings, and no weight loss after 4 or more weeks on a stable dose all suggest the dose is too low or absorption is insufficient